Details of the Drug Reposition

General Information of This Drug (ID: DMH5LME)

Drug Name
Levoleucovorin   DMH5LME
Synonyms FUSILEV (TN)
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
7 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rectum mucinous adenocarcinoma DIS75WFS N.A. Approved [1]
Colorectal carcinoma DIS5PYL0 N.A. Approved [1]
Colon adenocarcinoma DISDRE0J N.A. Approved [1]
Rectal adenocarcinoma DIS8R9VO 2B92 Approved [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Approved [1]
Pervasive developmental disorder DIS51975 6A00-6A0Z Approved [1]
Pneumocystis pneumonia DISFSOM3 CA40.20 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)
1 Discontinued in Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rectal signet ring cell adenocarcinoma DISORL5H N.A. Discontinued in Phase 1 [2]
------------------------------------------------------------------------------------
6 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Methotrexate toxicity DISU9Z8R N.A. Investigative [1]
Megaloblastic anemia DISVIZPC N.A. Investigative [1]
Colon mucinous adenocarcinoma DISXZXEI N.A. Investigative [1]
Gastric cancer DISXGOUK 2B72 Investigative [1]
Colon cancer DISVC52G 2B90.Z Investigative [1]
Anemia DISTVL0C 3A00-3A9Z Investigative [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)

References

1 Levoleucovorin FDA Label
2 A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015